» Articles » PMID: 23327719

Is Interleukin-17 Involved in the Interaction Between Polycystic Ovary Syndrome and Gingival Inflammation?

Overview
Journal J Periodontol
Date 2013 Jan 19
PMID 23327719
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Polycystic ovarian syndrome (PCOS) is a hormonal disorder of females of reproductive age that impacts their oral and systemic health. The aim of this study is to evaluate interleukin-17A (IL-17A), IL-17F, IL-17A/F, and IL-17E (IL-25) levels in gingival crevicular fluid (GCF), saliva, and serum of non-obese females with PCOS and with either a clinically healthy periodontium or gingivitis.

Methods: Thirty-one females with PCOS, 30 females with PCOS and gingivitis, and 12 systemically and periodontally healthy females participated in the study. Clinical periodontal measurements, body mass index, and Ferriman-Gallwey score (FGS) (a measure of hirsutism in females) were recorded. Circulating levels of sex hormones, cortisol, and insulin were also determined. Levels of IL-17 cytokines were measured by enzyme-linked immunosorbent assay.

Results: The general linear model multivariate analysis, adjusting for age or plaque index, showed that the two groups with PCOS had higher concentrations of IL-17A, IL-17F, and IL-17A/F in serum and higher levels of IL-17A and IL-17F in GCF and saliva but lower serum IL-17E than systemically healthy females. Levels of IL-17E were lowest in females with PCOS and gingivitis who also had the highest FGS. Serum IL-17A and IL-17F levels correlated positively with FGS and periodontal probing depth (all ρ >0.33; P <0.005). Serum IL-17E showed the reverse relationship and also correlated negatively with IL-17A (ρ >-0.28; P <0.05).

Conclusions: IL-17 levels are altered in non-obese females with PCOS and may influence gingival inflammation. Additional studies are warranted to clarify the relationship between PCOS and gingivitis.

Citing Articles

Infertility, IL-17, IL-33 and Microbiome Cross-Talk: The Extended ARIA-MeDALL Hypothesis.

Hamamah S, Barry F, Vannier S, Anahory T, Haahtela T, Anto J Int J Mol Sci. 2024; 25(22).

PMID: 39596052 PMC: 11594021. DOI: 10.3390/ijms252211981.


The IL-12 family of heterodimeric cytokines in polycystic ovarian syndrome: biological role in induction, regulation, and treatment.

Zheng M, Zhao F Immunol Res. 2024; 72(4):583-591.

PMID: 38771486 DOI: 10.1007/s12026-024-09487-4.


[Polycystic ovary syndrome is positively correlated with periodontitis: a prospective study].

Hu D, Zhang F, Li H, Xu X, Wen P, Zheng Z Nan Fang Yi Ke Da Xue Xue Bao. 2024; 44(1):36-44.

PMID: 38293974 PMC: 10878896. DOI: 10.12122/j.issn.1673-4254.2024.01.05.


Hypothalamic-Ovarian axis and Adiposity Relationship in Polycystic Ovary Syndrome: Physiopathology and Therapeutic Options for the Management of Metabolic and Inflammatory Aspects.

Lonardo M, Cacciapuoti N, Guida B, Di Lorenzo M, Chiurazzi M, Damiano S Curr Obes Rep. 2024; 13(1):51-70.

PMID: 38172476 PMC: 10933167. DOI: 10.1007/s13679-023-00531-2.


Comparative analysis of serum and saliva samples using Raman spectroscopy: a high-throughput investigation in patients with polycystic ovary syndrome and periodontitis.

Hu D, Wang J, Cheng T, Li H, Zhang F, Zhao D BMC Womens Health. 2023; 23(1):522.

PMID: 37794378 PMC: 10552415. DOI: 10.1186/s12905-023-02663-y.